top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
55513-0283-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (M.D.V.,M10) 10000 U/ML | IJ |
55513-0283-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (M.D.V.,M10) 10000 U/ML | IJ |
55513-0478-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (M.D.V.,M20) 20000 U/ML | IJ |
55513-0478-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN (M.D.V.,M20) 20000 U/ML | IJ |
55513-0530-01 | J1442 | INJECTION, FILGRASTIM (G-CSF), EXCLUDES BIOSIMILARS, 1 MICROGRAM | NEUPOGEN (S.D.V.,PF) 300 MCG/1 ML | IJ |
50742-0208-01 | J7507 | TACROLIMUS, IMMEDIATE RELEASE, ORAL, 1 MG | TACROLIMUS (HARD GELATIN) 1 MG | PO |
50742-0340-01 | J9305 | INJECTION, PEMETREXED, NOT OTHERWISE SPECIFIED, 10 MG | PEMETREXED (SDV,LYOPHILIZED) 100 MG | IV |
50742-0341-01 | J9305 | INJECTION, PEMETREXED, NOT OTHERWISE SPECIFIED, 10 MG | PEMETREXED (SDV,LYOPHILIZED) 500 MG | IV |
50742-0366-30 | J8565 | GEFITINIB, ORAL, 250 MG | GEFITINIB (FILM-COATED) 250 MG | PO |
50742-0401-02 | J9206 | INJECTION, IRINOTECAN, 20 MG | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | IV |
50742-0402-05 | J9206 | INJECTION, IRINOTECAN, 20 MG | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | IV |
50742-0405-10 | J9263 | INJECTION, OXALIPLATIN, 0.5 MG | OXALIPLATIN (PF) 5 MG/1 ML | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
